SYNG Pharmaceuticals Inc. (SYNG Pharma) is a pre-clinical stage biotechnology company dedicated to developing next generation diagnostic and therapeutic against endometriosis. The company is developing a novel peptide, SP011, to inhibit a target now known for its role in the proliferation of cells. SYNG Pharma has a potential to develop a treatment that would be a much needed alternative to currently available, partly ineffective, hormonal therapy. There are many other potential applications of SYNG Pharma technology including the treatment of fibroids and uterine sarcoma; breast and prostate cancer which may be further developed depending upon corporate interests and an opportunity for partnership.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Kingston, On K7l3n6, Ca
- Phone
- 613-532-9426
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- syngpharma.com
- Keywords
- Endometriosis, Blood Test, Non-hormonal Therapy, Menstrual Pain, Infertility, IVF, Women Health, Ovarian Cancer, Prostate Cancer.
- HQ
- Kingston, ON
Syng Pharmaceuticals Inc Questions
Syng Pharmaceuticals Inc's helpline number is 613-532-9426
Syng Pharmaceuticals Inc's website is syngpharma.com
Syng Pharmaceuticals Inc's LinkedIn profile is https://ca.linkedin.com/company/syng-pharma
Syng Pharmaceuticals Inc has
4 employees.
View email and phone details for 4
employees at Syng Pharmaceuticals Inc.
Syng Pharmaceuticals Inc's industry is
Biotechnology Research
Syng Pharmaceuticals Inc's top competitors are
Switch Ontario,
Pnuvax Incorporated,
Damona Pharmaceuticals,
Cipher Pharmaceuticals Inc. (Tsx: Cph) (Otcqx:cphrf),
Acic Pharmaceuticals Inc.,
Laurent Pharmaceuticals,
Goodcap Pharmaceuticals Inc.,
Apollo Green,
Wpd Pharmaceuticals Sp. Z O.o.,
Orange Neurosciences.
Syng Pharmaceuticals Inc's categories are Biotechnology Research
Syng Pharmaceuticals Inc's founding year is 2012
